OrthoPediatrics Analyst Price Targets - Benzinga

OrthoPediatrics Corp

KIDSNASDAQ

Trade with Public

Trade with Public

$22.06

Last update: Sep 11, 4:00 PM

Overview News Earnings Forecast EventsPrice TargetsFinancials Sentiment Ownership Compare Options Stock Report

OrthoPediatrics Analyst Price Targets

Wall Street analyst price targets and consensus rating for OrthoPediatrics (KIDS).

Price Target Range — 12 Quarters

Analyst Consensus — 10 Analysts

2S.Buy

7Buy

1Hold

Consensus RatingBuy# Analysts10Avg. Consensus PT$29Upside to Avg. PT+32.6%

Rating Trend — Last 9 Months

Recent Analyst Actions

See all ratings →

Date	Firm	Analyst	Action	Rating Change	Price Target
Aug 20, 2026	BTIG	Ryan Zimmerman	PT Raise	Buy	$24→$29
Aug 5, 2026	Piper Sandler	Matt O'Brien	PT Raise	Overweight	$22→$25
Aug 5, 2026	Needham	Mike Matson	PT Raise	Buy	$30→$35
Jul 16, 2026	Truist Securities	Richard Newitter	PT Raise	Hold	$17→$20
May 1, 2026	BTIG	Ryan Zimmerman	Maintained	Buy	$24
Mar 2, 2026	Truist Securities	Richard Newitter	PT Raise	Hold	$19→$20
Feb 27, 2026	Needham	Mike Matson	PT Raise	Buy	$26→$30
Feb 27, 2026	BTIG	Ryan Zimmerman	PT Raise	Buy	$23→$24
Jan 27, 2026	TD Cowen	Mathew Blackman	Initiate	Buy	$23
Dec 10, 2025	Canaccord Genuity	Caitlin Roberts	Initiate	Buy	$24
Oct 29, 2025	Needham	Mike Matson	PT Cut	Buy	$42→$26
Oct 29, 2025	BTIG	Ryan Zimmerman	Maintained	Buy	$23
Oct 10, 2025	Lake Street	Ben Haynor	PT Cut	Buy	$37→$34
Oct 10, 2025	Stifel	Rick Wise	PT Cut	Buy	$32→$20
Oct 10, 2025	JMP Securities	David Turkaly	PT Cut	Market Outperform	$35→$25
Oct 10, 2025	Piper Sandler	Matt O'Brien	PT Cut	Overweight	$30→$22
Oct 10, 2025	BTIG	Ryan Zimmerman	PT Cut	Buy	$39→$23
Aug 8, 2025	JMP Securities	David Turkaly	PT Cut	Market Outperform	$50→$35
Aug 6, 2025	BTIG	Ryan Zimmerman	PT Cut	Buy	$40→$39
May 8, 2025	Piper Sandler	Matt O'Brien	PT Cut	Overweight	$40→$30

More with Benzinga EdgeGet Access

Analyst Ratings News

PRO
BTIG Maintains Buy on OrthoPediatrics, Raises Price Target to $29

BTIG analyst Ryan Zimmerman maintains OrthoPediatrics (NASDAQ:KIDS) with a Buy and raises the price target from $24 to $29.

Benzinga Newsdesk

PRO
Piper Sandler Reiterates Overweight on OrthoPediatrics, Raises Price Target to $25

Piper Sandler analyst Matt O'Brien reiterates OrthoPediatrics (NASDAQ:KIDS) with a Overweight and raises the price target from $22 to $25.

Benzinga Newsdesk

PRO
Needham Maintains Buy on OrthoPediatrics, Raises Price Target to $35

Needham analyst Mike Matson maintains OrthoPediatrics (NASDAQ:KIDS) with a Buy and raises the price target from $30 to $35.

Benzinga Newsdesk

PRO
Truist Securities Maintains Hold on OrthoPediatrics, Raises Price Target to $20

Truist Securities analyst Richard Newitter maintains OrthoPediatrics (NASDAQ:KIDS) with a Hold and raises the price target from $17 to $20.

Benzinga Newsdesk

PRO
BTIG Reiterates Buy on OrthoPediatrics, Maintains $24 Price Target

BTIG analyst Ryan Zimmerman reiterates OrthoPediatrics (NASDAQ:KIDS) with a Buy and maintains $24 price target.

Benzinga Newsdesk

Beyond The Numbers: 5 Analysts Discuss OrthoPediatrics Stock

Benzinga Insights